The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...

There are so many false promises online when it comes to losing weight. Here are my top weight loss technologies that ...

The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

Ozempic's dramatic weight loss results come with an unexpected complication - hair thinning. Learn why it happens, who's at ...

Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...

Roxy Jacenko continued her rigorous health kick on Monday as she was spotted enjoying a green juice with friends in ritzy ...

After his insurance company refused to pay for a sleeve gastrectomy, Matthew Smith went south. Way south! This story is part ...

Over the last few years, there has been an increase in the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss ... as an off-label treatment for weight management ...

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.